A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia
| Image |  |
|---|---|
| Description | scientific article published on 20 November 2014 |
| Author/s |
author: Andrew W. Roberts Andrew J. McLachlan Ian Kerridge Hayley S. Ramshaw Angel F. Lopez |
| Publication date | November 20, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |